{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:44:13Z","timestamp":1793922253195,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07845-y","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:29:47Z","timestamp":1774052987000},"page":"5042-5049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex-specific differences in patients with differentiated thyroid carcinoma and their possible impact on survival"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3526-8601","authenticated-orcid":false,"given":"Marieke","family":"Heinrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Blickle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jedamzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kohnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kerscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Anton","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"5","key":"7845_CR1","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: Rev Jama. 2024;331(5):425\u201335.","journal-title":"Thyroid Cancer: Rev Jama"},{"issue":"3","key":"7845_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"7845_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.29251","volume":"136","author":"C La Vecchia","year":"2015","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136(9):2187\u201395.","journal-title":"Int J Cancer"},{"issue":"4","key":"7845_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"7845_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/a-0859-7454","volume":"58","author":"J Farahati","year":"2019","unstructured":"Farahati J, M\u00e4der U, Gilman E, G\u00f6rges R, Maric I, Binse I, et al. Changing trends of incidence and prognosis of thyroid carcinoma. Nuklearmedizin. 2019;58(2):86\u201392.","journal-title":"Nuklearmedizin"},{"issue":"10387","key":"7845_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401(10387):1531\u201344.","journal-title":"Lancet"},{"issue":"6","key":"7845_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"RM Tuttle","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 2017;27(6):751\u20136.","journal-title":"Thyroid"},{"issue":"8","key":"7845_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, Bischoff L, Bloom G, Brent GA, et al. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid\u00ae. 2025;35(8):841\u2013985.","journal-title":"Thyroid\u00ae"},{"key":"7845_CR9","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie (DGAV) DGfED, Deutsche Gesellschaft f\u00fcr Nuklearmedizin (DGN), et al. S3-Leitlinie Schiddr\u00fcsenkarzinom2025."},{"issue":"1","key":"7845_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1210\/jc.2012-2458","volume":"98","author":"FA Verburg","year":"2013","unstructured":"Verburg FA, M\u00e4der U, Tanase K, Thies E-D, Diessl S, Buck AK, et al. Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients\u2009\u2265\u200945 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients. J Clin Endocrinol Metabolism. 2013;98(1):172\u201380.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"7845_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/thy.2017.0265","volume":"28","author":"M Shteinshnaider","year":"2017","unstructured":"Shteinshnaider M, Muallem Kalmovich L, Koren S, Or K, Cantrell D, Benbassat C. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM\/AJCC Classification System: A Comparative Study. Thyroid\u00ae. 2017;28(2):201\u20139.","journal-title":"Thyroid\u00ae"},{"key":"7845_CR12","first-page":"251","volume-title":"TNM Classification of Malignant Tumours 9th Edition","author":"J Bierley","year":"2025","unstructured":"Bierley J, Giuliani M, O`Sullivan B, Rous B, Van Eycken E. TNM Classification of Malignant Tumours 9th Edition. 9th, editor. ed. USA and UK: Wiley; 2025. p. 251.","edition":"9"},{"issue":"1","key":"7845_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00003088-200140010-00002","volume":"40","author":"PL Bonate","year":"2001","unstructured":"Bonate PL. A brief introduction to Monte Carlo simulation. Clin Pharmacokinet. 2001;40(1):15\u201322.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"7845_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/jech.2003.009654","volume":"58","author":"D Eayres","year":"2004","unstructured":"Eayres D, Williams ES. Evaluation of methodologies for small area life expectancy estimation. J Epidemiol Community Health. 2004;58(3):243\u20139.","journal-title":"J Epidemiol Community Health"},{"issue":"20","key":"7845_CR15","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/jnci\/djq366","volume":"102","author":"N Howlader","year":"2010","unstructured":"Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102(20):1584\u201398.","journal-title":"J Natl Cancer Inst"},{"key":"7845_CR16","first-page":"101","volume":"6","author":"F Ederer","year":"1961","unstructured":"Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101\u201321.","journal-title":"Natl Cancer Inst Monogr"},{"issue":"14","key":"7845_CR17","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.ejca.2011.03.011","volume":"47","author":"T Hakulinen","year":"2011","unstructured":"Hakulinen T, Sepp\u00e4 K, Lambert PC. Choosing the relative survival method for cancer survival estimation. Eur J Cancer. 2011;47(14):2202\u201310.","journal-title":"Eur J Cancer"},{"key":"7845_CR18","unstructured":"Cho H, Howlader N, Mariotto AB, Cronin KA. Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, NCI, Technical Report. 2011;1:2011."},{"issue":"10","key":"7845_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jamainternmed.2021.4804","volume":"181","author":"K LeClair","year":"2021","unstructured":"LeClair K, Bell KJL, Furuya-Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of Gender Inequity in Thyroid Cancer Diagnosis: Differences by Sex in US Thyroid Cancer Incidence Compared With a Meta-analysis of Subclinical Thyroid Cancer Rates at Autopsy. JAMA Intern Med. 2021;181(10):1351\u20138.","journal-title":"JAMA Intern Med"},{"key":"7845_CR20","unstructured":"Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M et al. SEER cancer statistics review, 1975\u20132005. Bethesda, MD: National Cancer Institute. 2008;2999."},{"key":"7845_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","volume":"84","author":"C Radkiewicz","year":"2017","unstructured":"Radkiewicz C, Johansson ALV, Dickman PW, Lambe M, Edgren G. Sex differences in cancer risk and survival: A Swedish cohort study. Eur J Cancer. 2017;84:130\u201340.","journal-title":"Eur J Cancer"},{"issue":"1","key":"7845_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/thy.2022.0353","volume":"33","author":"A Wilhelm","year":"2023","unstructured":"Wilhelm A, Conroy PC, Calthorpe L, Shui AM, Kitahara CM, Roman SA, et al. Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid Cancer and Distant Metastases in the United States, 1992\u20132018. Thyroid. 2023;33(1):63\u201373.","journal-title":"Thyroid"},{"issue":"6","key":"7845_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/thy.2012.0269","volume":"23","author":"N Nilubol","year":"2013","unstructured":"Nilubol N, Zhang L, Kebebew E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid. 2013;23(6):695\u2013702.","journal-title":"Thyroid"},{"issue":"1","key":"7845_CR24","first-page":"53","volume":"12","author":"EM Aboelnaga","year":"2015","unstructured":"Aboelnaga EM, Ahmed RA. Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution. Cancer Biol Med. 2015;12(1):53\u20139.","journal-title":"Cancer Biol Med"},{"issue":"6","key":"7845_CR25","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.surg.2013.04.033","volume":"154","author":"EJ Kuo","year":"2013","unstructured":"Kuo EJ, Roman SA, Sosa JA. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients. Surgery. 2013;154(6):1246\u201353. discussion 53\u20134.","journal-title":"Surgery"},{"issue":"1","key":"7845_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.surg.2018.04.078","volume":"165","author":"AR Shaha","year":"2019","unstructured":"Shaha AR, Migliacci JC, Nixon IJ, Wang LY, Wong RJ, Morris LGT, et al. Stage migration with the new American Joint Committee on Cancer (AJCC) staging system (8th edition) for differentiated thyroid cancer. Surgery. 2019;165(1):6\u201311.","journal-title":"Surgery"},{"issue":"36","key":"7845_CR27","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1200\/JCO.2016.68.9372","volume":"34","author":"MA Adam","year":"2016","unstructured":"Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. J Clin Oncol. 2016;34(36):4415\u201320.","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:34:36Z","timestamp":1781642076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7845"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07845-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the local Ethics Committee of the Julius-Maximilians-University Wuerzburg in view of the retrospective nature of the study and all procedures being performed were part of the routine care (waiver no. 20231103 02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Author F.A. Verburg has received speaker and consultancy Fees from GE Healthcare (paid to the employer), speaker fees from Bayer (paid to the employer) and Consultancy fees von Immedica (paid to the employer).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}